Importantly, bone resorption assay showed that CM-BC/circIKBKB-treated osteoclasts possessed higher bone-resorbing activity (Fig. 2e), resulting in an elevated the level of bone matrix-released transforming growth factor beta (TGF-β) and consequently promoted BC cells proliferation (Fig. S2e). This evidence concerns the gene TGFB1 and breast cancer.